Medchemexpress LLC Tivantinib | 905854-02-6 | 99.6% | C23H19N3O2 | 100 MG

Supplier:  Medchemexpress LLC HY50686100MG

Tivantinib is a highly selective c-Met tyrosine kinase inhibitor, notable for its low molecular weight and as the first orally available selective inhibitor of c-Met. It selectively inhibits c-Met activity in cell-free and cell-based assays, leading to dose-dependent loss of proliferative capacity or caspase-dependent apoptosis in c-Met-expressing cancer cell lines.

• Highly selective c-Met tyrosine kinase inhibitor
• First orally available selective inhibitor of c-Met
• Inhibits c-Met activity in cell-free and cell-based assays
• Induces dose-dependent loss of proliferative capacity or caspase-dependent apoptosis in c-Met-expressing cancer cell lines
• Inhibits human recombinant c-Met with a Ki of approximately 355 nM

Catalog No. 50-003-58749